To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Ian Murray (Lab) voted Aye - in line with the party majority and against the House
One of 120 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 171 Noes - 265
Division Vote (Commons)
25 Mar 2024 - Investigatory Powers (Amendment)Bill [Lords] - View Vote Context
Ian Murray (Lab) voted Aye - in line with the party majority and against the House
One of 121 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 171 Noes - 265
Written Question
Advanced Therapy Medicinal Products: Scotland
Friday 22nd March 2024

Asked by: Ian Murray (Labour - Edinburgh South)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to help support research into cell and gene therapy in Scotland.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult (CGTC).

DSIT also invested £10 million - alongside £10 million from Scottish Enterprise – to support a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Glasgow.

The Vaccine Taskforce provided funding for a state-of-the art CGTC facility in Braintree to accelerate the development and manufacturing of advanced therapies at clinical and commercial scale.

My department also supported CGTC to establish apprenticeships and training programmes to upskill people across the UK.


Written Question
Advanced Therapy Medicinal Products: Scotland
Thursday 21st March 2024

Asked by: Ian Murray (Labour - Edinburgh South)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to increase Scotland’s (a) manufacturing capacity for and (b) delivery of cell and gene therapies.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

The government is investing significantly to support manufacturing and delivery of cell and gene therapies.

Since 2021, government has launched three UK-wide capital grant schemes – up to £118 million of funds – to incentivise manufacturing investments, including in advanced therapies. Last year, government announced a further £520 million to increase investment in Life Sciences manufacturing.

The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult which also coordinates the Advanced Therapy Treatment Centre network.


Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Ian Murray (Lab) voted Aye - in line with the party majority and against the House
One of 154 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 218 Noes - 305
Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Ian Murray (Lab) voted Aye - in line with the party majority and against the House
One of 151 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 217 Noes - 305
Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Ian Murray (Lab) voted Aye - in line with the party majority and against the House
One of 152 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 219 Noes - 306
Division Vote (Commons)
19 Mar 2024 - Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Bill [Lords] - View Vote Context
Ian Murray (Lab) voted Aye - in line with the party majority and against the House
One of 153 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 224 Noes - 301
Division Vote (Commons)
18 Mar 2024 - Safety of Rwanda (Asylum and Immigration) Bill - View Vote Context
Ian Murray (Lab) voted No - in line with the party majority and against the House
One of 181 Labour No votes vs 0 Labour Aye votes
Vote Tally: Ayes - 322 Noes - 249
Division Vote (Commons)
18 Mar 2024 - Safety of Rwanda (Asylum and Immigration) Bill - View Vote Context
Ian Murray (Lab) voted No - in line with the party majority and against the House
One of 179 Labour No votes vs 0 Labour Aye votes
Vote Tally: Ayes - 320 Noes - 250